newsfilter
← Latest News
GlobeNewswire·

Clearmind Medicine Successfully Completes Part A of its FDA Regulated Phase I/II Trial

Vancouver, Canada, July 28, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. ("Clearmind" or "Company") (NASDAQ:CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic